♥
ISIN : INE075I01017
NSE : HCG
BSE : 539787
Face Value : 10
Industry : Miscellaneous
EPS : 3.43
EPS (TTM) : 3.75
Price to Earning (P/E) : 158.05
Book Value : 58.02
Price to Bookvalue (P/B) : 9.34
Dividend Yield : 0 %
Return on Equity (ROE) : 4.99 %
Return on Capital Employed (ROCE) : 12.79 %
Healthcare Global Enterprises Limited
ISIN : INE075I01017
NSE : HCG
BSE : 539787
Face Value : 10
Industry : Miscellaneous
EPS : 3.43
EPS (TTM) : 3.75
Price to Earning (P/E) : 158.05
Book Value : 58.02
Price to Bookvalue (P/B) : 9.34
Dividend Yield : 0 %
Return on Equity (ROE) : 4.99 %
Return on Capital Employed (ROCE) : 12.79 %
Healthcare Global share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 528 - 528.5 0.1 % |
| Low / High | 518.55 - 532.95 2.8 % |
| Trade Volume | 4,899 |
| 52 Week Low / High | 513.4 - 804.3 56.7 % |
-
YOU MAY ALSO LIKE
- Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Share Market basics for beginners
Share Market jargons in simple terms - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Stock market course tutorial
Stock Market Investment Course explained in simple words. - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
CONSOLIDATED QUARTERLY RESULT FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 3646.3 | 4080.5 | 4200 | 4246.8 | 4417.1 | 4606.8 | 4869.4 | 4698.7 | 4946.3 | 5255.8 |
| Total Income | 3676.4 | 4109.6 | 4219.7 | 4283.3 | 4463.6 | 4631 | 4903.4 | 4759.4 | 4996.8 | 5343.9 |
| Total Expenditure | 3014.8 | 3358.9 | 3453.1 | 3491.7 | 3653.9 | 3863.7 | 4023.1 | 3912.5 | 4026 | 4346.7 |
| Other Income | 30.1 | 29.1 | 19.7 | 36.5 | 46.5 | 24.2 | 34 | 60.7 | 50.5 | 88.1 |
| Operating Profit | 661.6 | 750.7 | 766.6 | 791.6 | 809.7 | 767.3 | 880.3 | 846.9 | 970.8 | 997.2 |
| Interest | 241.4 | 249.8 | 258.1 | 270.8 | 256.3 | 255.5 | 268.9 | 294.6 | 268.4 | 337.1 |
| Exceptional Items | 39 | |||||||||
| PBDT | 420.2 | 500.9 | 508.5 | 520.8 | 553.4 | 511.8 | 611.4 | 552.3 | 741.4 | 660.1 |
| Depreciation | 411 | 396.7 | 408.3 | 407.7 | 422 | 410.1 | 432.1 | 441.6 | 459.8 | 470.1 |
| Profit Before Tax | 9.2 | 104.2 | 100.2 | 113.1 | 131.4 | 101.7 | 179.3 | 110.7 | 281.6 | 190 |
| Tax | -13.3 | 79.4 | 47.3 | 71 | 74.8 | 68.7 | 71.4 | 76.3 | 47.6 | 53.6 |
| Profit After Tax | 22.5 | 24.8 | 52.9 | 42.1 | 56.6 | 33 | 107.9 | 34.4 | 234 | 136.4 |
| Net Profit | 22.5 | 24.8 | 52.9 | 42.1 | 56.6 | 33 | 107.9 | 34.4 | 234 | 136.4 |
| Equity Capital | 1390.1 | 1390.2 | 1390.8 | 1390.9 | 1391.2 | 1391.6 | 1392.6 | 1392.8 | 1392.9 | 1393.5 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 0.43 | 0.44 | 0.53 | 0.54 | 0.6 | 0.55 | 0.97 | 0.41 | 1.53 | 0.87 |
| Diluted Eps After Extraordinary Items | 0.43 | 0.43 | 0.53 | 0.54 | 0.6 | 0.54 | 0.97 | 0.41 | 1.51 | 0.86 |
| Diluted Eps Before Extraordinary Items | 0.43 | 0.43 | 0.53 | 0.54 | 0.6 | 0.54 | 0.97 | 0.41 | 1.51 | 0.86 |
STANDALONE QUARTERLY RESULT FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 2201.9 | 2431.7 | 2530.7 | 2526.8 | 2586.7 | 2722.3 | 2827.5 | 2672.1 | 2803.8 | 2936.1 |
| Total Income | 2224.4 | 2450.4 | 2543.4 | 2547.8 | 2622.3 | 2740.6 | 2848.8 | 2727.3 | 2845 | 3041.1 |
| Total Expenditure | 1797.6 | 1972.1 | 2063.5 | 2030.6 | 2186.9 | 2246.9 | 2323.4 | 2204.8 | 2255.3 | 2437.2 |
| Other Income | 22.5 | 18.7 | 12.7 | 21 | 35.6 | 18.3 | 21.3 | 55.2 | 41.2 | 105 |
| Operating Profit | 426.8 | 478.3 | 479.9 | 517.2 | 435.4 | 493.7 | 525.4 | 522.5 | 589.7 | 603.9 |
| Interest | 92.2 | 97.2 | 116.7 | 105.3 | 95.7 | 96.9 | 109.8 | 132.1 | 140.9 | 193.4 |
| Exceptional Items | -270 | -30 | -161 | |||||||
| PBDT | 64.6 | 381.1 | 363.2 | 411.9 | 309.7 | 396.8 | 415.6 | 390.4 | 287.8 | 410.5 |
| Depreciation | 221.9 | 217 | 224 | 218.1 | 230.6 | 216.4 | 232.8 | 240.9 | 251.9 | 258.4 |
| Profit Before Tax | -157.3 | 164.1 | 139.2 | 193.8 | 79.1 | 180.4 | 182.8 | 149.5 | 35.9 | 152.1 |
| Tax | 21.9 | 55.6 | 29.2 | 52.2 | 37.3 | 43.5 | 45.8 | 66.2 | 53.5 | 34.9 |
| Profit After Tax | -179.2 | 108.5 | 110 | 141.6 | 41.8 | 136.9 | 137 | 83.3 | -17.6 | 117.2 |
| Net Profit | -179.2 | 108.5 | 110 | 141.6 | 41.8 | 136.9 | 137 | 83.3 | -17.6 | 117.2 |
| Equity Capital | 1390.1 | 1390.2 | 1390.8 | 1390.9 | 1391.2 | 1391.6 | 1392.6 | 1392.8 | 1392.9 | 1393.5 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -1.29 | 0.78 | 0.79 | 1.02 | 0.3 | 0.98 | 0.98 | 0.6 | -0.13 | 0.84 |
| Diluted Eps After Extraordinary Items | -1.29 | 0.78 | 0.79 | 1.01 | 0.3 | 0.98 | 0.98 | 0.59 | -0.13 | 0.83 |
| Diluted Eps Before Extraordinary Items | -1.29 | 0.78 | 0.79 | 1.01 | 0.3 | 0.98 | 0.98 | 0.59 | -0.13 | 0.83 |
CONSOLIDATED ANNUAL RESULT FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 13977.9 | 16944.4 | 19121.2 |
| Total Income | 14104.6 | 17076.2 | 19290.6 |
| Total Expenditure | 11598.1 | 13957.6 | 15825.3 |
| Other Income | 126.7 | 131.8 | 169.4 |
| Operating Profit | 2506.5 | 3118.6 | 3465.3 |
| Interest | 977.7 | 1035 | 1087.4 |
| Exceptional Items | 946.1 | 39 | |
| PBDT | 2474.9 | 2083.6 | 2416.9 |
| Depreciation | 1582.8 | 1634.7 | 1743.6 |
| Profit Before Tax | 892.1 | 448.9 | 673.3 |
| Tax | 488.5 | 272.5 | 264 |
| Profit After Tax | 403.6 | 176.4 | 409.3 |
| Net Profit | 403.6 | 176.4 | 409.3 |
| Equity Capital | 1390.1 | 1391.2 | 1392.9 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 7312.8 | 7214.1 | 6864.9 |
| Calculated EPS | 3.87 | 2.11 | 3.46 |
| Diluted Eps After Extraordinary Items | 3.97 | 2.1 | 3.43 |
| Diluted Eps Before Extraordinary Items | 3.97 | 2.1 | 3.43 |
STANDALONE ANNUAL RESULT FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 8519.6 | 10075.9 | 11025.7 |
| Total Income | 8622.5 | 10163.9 | 11161.7 |
| Total Expenditure | 7029.6 | 8253.1 | 9030.4 |
| Other Income | 102.9 | 88 | 136 |
| Operating Profit | 1592.9 | 1910.8 | 2131.3 |
| Interest | 428 | 414.9 | 479.7 |
| Exceptional Items | 529.1 | -30 | -161 |
| PBDT | 1694 | 1465.9 | 1490.6 |
| Depreciation | 883.6 | 889.7 | 942 |
| Profit Before Tax | 810.4 | 576.2 | 548.6 |
| Tax | 427.9 | 174.3 | 209 |
| Profit After Tax | 382.5 | 401.9 | 339.6 |
| Net Profit | 382.5 | 401.9 | 339.6 |
| Equity Capital | 1390.1 | 1391.2 | 1392.9 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 9586.8 | 10060.1 | 10493 |
| Calculated EPS | 2.75 | 2.89 | 2.44 |
| Diluted Eps After Extraordinary Items | 2.83 | 2.88 | 2.42 |
| Diluted Eps Before Extraordinary Items | 2.83 | 2.88 | 2.42 |
CONSOLIDATED PROFIT / LOSS FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 1009.18 Cr | 1394.78 Cr | 1691.41 Cr | 1907.87 Cr |
| Sales | 62.26 Cr | 80.88 Cr | 1592.08 Cr | 1796.15 Cr |
| Job Work/ Contract Receipts | 0 | 0 | 83.97 Cr | 93.76 Cr |
| Processing Charges / Service Income | 941.75 Cr | 1302.26 Cr | 0 | 0 |
| Net Sales | 1009.18 Cr | 1394.78 Cr | 1691.41 Cr | 1907.87 Cr |
| Increase/Decrease in Stock | 2.15 Cr | -6.07 Cr | -8.31 Cr | -3.95 Cr |
| Raw Material Consumed | 238.16 Cr | 360.98 Cr | 432.38 Cr | 479.37 Cr |
| Other Direct Purchases / Brought in cost | 238.16 Cr | 360.98 Cr | 432.38 Cr | 479.37 Cr |
| Power & Fuel Cost | 31.75 Cr | 34.54 Cr | 36.89 Cr | 39.35 Cr |
| Electricity & Power | 31.75 Cr | 34.54 Cr | 36.89 Cr | 39.35 Cr |
| Employee Cost | 195.94 Cr | 233.65 Cr | 275.12 Cr | 308.24 Cr |
| Salaries, Wages & Bonus | 172.66 Cr | 208.28 Cr | 240.07 Cr | 267.36 Cr |
| Contributions to EPF & Pension Funds | 14.6 Cr | 14.46 Cr | 15.8 Cr | 17.02 Cr |
| Workmen and Staff Welfare Expenses | 6.76 Cr | 7.8 Cr | 12.74 Cr | 16.01 Cr |
| Other Manufacturing Expenses | 86.78 Cr | 87.74 Cr | 456.89 Cr | 520.39 Cr |
| Repairs and Maintenance | 49 Cr | 56.38 Cr | 49.07 Cr | 49.57 Cr |
| General and Administration Expenses | 301.92 Cr | 404.06 Cr | 176.67 Cr | 204.67 Cr |
| Rent , Rates & Taxes | 19.3 Cr | 26.3 Cr | 29.97 Cr | 41.6 Cr |
| Insurance | 1.94 Cr | 2.49 Cr | 2.83 Cr | 2.76 Cr |
| Printing and stationery | 2.88 Cr | 3.68 Cr | 3.89 Cr | 6.9 Cr |
| Professional and legal fees | 242.41 Cr | 329.61 Cr | 56.9 Cr | 56.46 Cr |
| Traveling and conveyance | 6.53 Cr | 9.21 Cr | 16.3 Cr | 18.36 Cr |
| Selling and Distribution Expenses | 13.57 Cr | 18.11 Cr | 0 | 0 |
| Advertisement & Sales Promotion | 13.57 Cr | 18.11 Cr | 33.65 Cr | 40.12 Cr |
| Miscellaneous Expenses | 16.58 Cr | 26.82 Cr | 41.54 Cr | 34.47 Cr |
| Bad debts /advances written off | 0 | 0 | 0 | 43.2 Lk |
| Provision for doubtful debts | 7.62 Cr | 15.06 Cr | 0 | 22.56 Cr |
| Loss on disposal of fixed assets(net) | 5.2 Lk | 64.3 Lk | 1.32 Cr | 1.77 Cr |
| Total Expenditure | 886.86 Cr | 1159.81 Cr | 1411.17 Cr | 1582.53 Cr |
| Other Income | 21.2 Cr | 15.67 Cr | 31.63 Cr | 21.19 Cr |
| Interest Received | 15.61 Cr | 11.56 Cr | 11.82 Cr | 12.7 Cr |
| Profit on sale of Fixed Assets | 14.1 Lk | 0 | 3.5 Lk | 21.7 Lk |
| Provision Written Back | 10,000 | 0 | 22.6 Lk | 64.1 Lk |
| Foreign Exchange Gains | 1.4 Lk | 48.7 Lk | 34.6 Lk | 44.6 Lk |
| Operating Profit | 143.53 Cr | 250.64 Cr | 311.87 Cr | 346.53 Cr |
| Interest | 119.17 Cr | 97.76 Cr | 103.5 Cr | 108.74 Cr |
| Interest on Term Loan | 42.45 Cr | 27.87 Cr | 35.1 Cr | 38.93 Cr |
| Bank Charges etc | 6.23 Cr | 10.48 Cr | 7 Cr | 7.66 Cr |
| PBDT | 24.36 Cr | 152.87 Cr | 208.37 Cr | 237.79 Cr |
| Depreciation | 159.22 Cr | 158.28 Cr | 163.47 Cr | 174.36 Cr |
| Profit Before Taxation & Exceptional Items | -134.85 Cr | -5.41 Cr | 44.9 Cr | 63.44 Cr |
| Exceptional Income / Expenses | -93.45 Cr | 94.61 Cr | 0 | 3.9 Cr |
| Profit Before Tax | -228.3 Cr | 87.77 Cr | 44.88 Cr | 67.73 Cr |
| Provision for Tax | -7.56 Cr | 48.85 Cr | 27.25 Cr | 26.4 Cr |
| Current Income Tax | 4.71 Cr | 23.71 Cr | 15.38 Cr | 34.32 Cr |
| Deferred Tax | -12.27 Cr | 25.44 Cr | 26.69 Cr | -7.92 Cr |
| Profit After Tax | -220.74 Cr | 38.92 Cr | 17.63 Cr | 41.33 Cr |
| Minority Interest | 27.64 Cr | 14.81 Cr | 11.72 Cr | 6.82 Cr |
| Share of Associate | -36.5 Lk | 0 | 0 | 0 |
| Consolidated Net Profit | -193.46 Cr | 53.73 Cr | 29.35 Cr | 48.16 Cr |
| Profit Balance B/F | -292.22 Cr | -475.1 Cr | -436.55 Cr | -452.24 Cr |
| Appropriations | -485.68 Cr | -421.37 Cr | -407.2 Cr | -404.09 Cr |
| Other Appropriation | -10.58 Cr | 15.18 Cr | 45.04 Cr | 92.16 Cr |
| Earnings Per Share | -15.43 | 3.87 | 2.11 | 3.46 |
| Adjusted EPS | -15.43 | 3.87 | 2.11 | 3.46 |
STANDALONE PROFIT / LOSS FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 608.86 Cr | 849.83 Cr | 1005.57 Cr | 1099.29 Cr |
| Sales | 38.65 Cr | 61.12 Cr | 951.55 Cr | 1041.8 Cr |
| Job Work/ Contract Receipts | 0 | 0 | 44.61 Cr | 46.1 Cr |
| Processing Charges / Service Income | 566.12 Cr | 780.44 Cr | 0 | 0 |
| Net Sales | 608.86 Cr | 849.83 Cr | 1005.57 Cr | 1099.29 Cr |
| Increase/Decrease in Stock | 56.4 Lk | -2.94 Cr | -3.92 Cr | 63 Lk |
| Raw Material Consumed | 137.9 Cr | 213.26 Cr | 240.2 Cr | 245.08 Cr |
| Other Direct Purchases / Brought in cost | 137.9 Cr | 213.26 Cr | 240.2 Cr | 245.08 Cr |
| Power & Fuel Cost | 18.5 Cr | 19.76 Cr | 18.82 Cr | 19.2 Cr |
| Electricity & Power | 18.5 Cr | 19.76 Cr | 18.82 Cr | 19.2 Cr |
| Employee Cost | 136.72 Cr | 156.63 Cr | 175.03 Cr | 197.15 Cr |
| Salaries, Wages & Bonus | 118.81 Cr | 138.68 Cr | 150.21 Cr | 168.26 Cr |
| Contributions to EPF & Pension Funds | 10.4 Cr | 9.28 Cr | 9.5 Cr | 10.39 Cr |
| Workmen and Staff Welfare Expenses | 5.67 Cr | 5.84 Cr | 9.35 Cr | 11.25 Cr |
| Other Manufacturing Expenses | 57.86 Cr | 58.84 Cr | 253.8 Cr | 276.58 Cr |
| Repairs and Maintenance | 32.55 Cr | 36.58 Cr | 28.78 Cr | 28.51 Cr |
| General and Administration Expenses | 165.43 Cr | 229.67 Cr | 115.1 Cr | 140.37 Cr |
| Rent , Rates & Taxes | 9.13 Cr | 14.79 Cr | 16.78 Cr | 26.37 Cr |
| Insurance | 96.5 Lk | 1.35 Cr | 1.35 Cr | 1.59 Cr |
| Printing and stationery | 2.13 Cr | 2.25 Cr | 2.63 Cr | 4.21 Cr |
| Professional and legal fees | 129.81 Cr | 184.09 Cr | 41.87 Cr | 47.22 Cr |
| Traveling and conveyance | 5.06 Cr | 6.95 Cr | 11.97 Cr | 13.44 Cr |
| Selling and Distribution Expenses | 7.48 Cr | 9.99 Cr | 0 | 0 |
| Advertisement & Sales Promotion | 7.48 Cr | 9.99 Cr | 18.18 Cr | 21.84 Cr |
| Miscellaneous Expenses | 10.95 Cr | 17.76 Cr | 37.48 Cr | 24.04 Cr |
| Provision for doubtful debts | 4.14 Cr | 9.78 Cr | 31.71 Cr | 0 |
| Loss on disposal of fixed assets(net) | 6.4 Lk | 8.1 Lk | 1.19 Cr | 0 |
| Total Expenditure | 535.4 Cr | 702.96 Cr | 836.51 Cr | 903.04 Cr |
| Other Income | 24.02 Cr | 12.42 Cr | 22.02 Cr | 16.88 Cr |
| Interest Received | 18.89 Cr | 7.58 Cr | 6.34 Cr | 7.69 Cr |
| Profit on sale of Fixed Assets | 14 Lk | 0 | 0 | 37.6 Lk |
| Provision Written Back | 0 | 0 | 22.6 Lk | 69.7 Lk |
| Foreign Exchange Gains | 0 | 36.5 Lk | 40.4 Lk | 51.8 Lk |
| Operating Profit | 97.48 Cr | 159.28 Cr | 191.08 Cr | 213.13 Cr |
| Interest | 62.86 Cr | 42.8 Cr | 41.49 Cr | 47.97 Cr |
| Interest on Term Loan | 21.51 Cr | 10.69 Cr | 9.13 Cr | 13.29 Cr |
| Bank Charges etc | 3.91 Cr | 4.57 Cr | 3.38 Cr | 2.96 Cr |
| PBDT | 34.62 Cr | 116.49 Cr | 149.59 Cr | 165.16 Cr |
| Depreciation | 86.58 Cr | 88.36 Cr | 88.97 Cr | 94.2 Cr |
| Profit Before Taxation & Exceptional Items | -51.96 Cr | 28.13 Cr | 60.62 Cr | 70.96 Cr |
| Exceptional Income / Expenses | -153.1 Cr | 52.91 Cr | -3 Cr | -16.1 Cr |
| Profit Before Tax | -205.06 Cr | 81.04 Cr | 57.62 Cr | 54.86 Cr |
| Provision for Tax | -13.51 Cr | 42.79 Cr | 17.43 Cr | 20.91 Cr |
| Current Income Tax | 0 | 15.7 Cr | 7 Cr | 25.19 Cr |
| Deferred Tax | -13.51 Cr | 27.09 Cr | 10.43 Cr | -4.28 Cr |
| Profit After Tax | -191.55 Cr | 38.25 Cr | 40.19 Cr | 33.96 Cr |
| Consolidated Net Profit | -191.55 Cr | 38.25 Cr | 40.19 Cr | 33.96 Cr |
| Profit Balance B/F | -55.11 Cr | -246.66 Cr | -208.29 Cr | -168.1 Cr |
| Appropriations | -246.66 Cr | -208.4 Cr | -168.1 Cr | -134.14 Cr |
| Other Appropriation | 0 | -11.1 Lk | 0 | -10.6 Lk |
| Earnings Per Share | -15.28 | 2.75 | 2.89 | 2.44 |
| Adjusted EPS | -15.28 | 2.75 | 2.89 | 2.44 |
CONSOLIDATED CASH FLOW FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -228.66 Cr | 87.77 Cr | 44.88 Cr | 67.73 Cr |
| Adjustment | 361.93 Cr | 166.57 Cr | 275.29 Cr | 291.41 Cr |
| Changes In working Capital | -50.71 Cr | -10.52 Cr | -45.87 Cr | -27.19 Cr |
| Cash Flow after changes in Working Capital | 82.55 Cr | 243.83 Cr | 274.31 Cr | 331.95 Cr |
| Cash Flow from Operating Activities | 120.52 Cr | 220.12 Cr | 251.59 Cr | 284.58 Cr |
| Cash Flow from Investing Activities | -171.1 Cr | 124.59 Cr | -133.03 Cr | -225.73 Cr |
| Cash Flow from Financing Activitie | 112.24 Cr | -154.88 Cr | -140.07 Cr | -64.02 Cr |
| Net Cash Inflow / Outflow | 61.66 Cr | 189.82 Cr | -21.51 Cr | -5.16 Cr |
| Opening Cash & Cash Equivalents | -58.79 Cr | 2.86 Cr | 192.69 Cr | 171.18 Cr |
| Closing Cash & Cash Equivalent | 2.86 Cr | 192.69 Cr | 171.18 Cr | 166.02 Cr |
STANDALONE CASH FLOW FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -205.06 Cr | 81.04 Cr | 57.62 Cr | 54.86 Cr |
| Adjustment | 284.92 Cr | 79.09 Cr | 150.49 Cr | 167.98 Cr |
| Changes In working Capital | -49.4 Cr | -21.02 Cr | -60.47 Cr | 4.99 Cr |
| Cash Flow after changes in Working Capital | 30.45 Cr | 139.12 Cr | 147.64 Cr | 227.83 Cr |
| Cash Flow from Operating Activities | 70.89 Cr | 124.4 Cr | 130.4 Cr | 194.71 Cr |
| Cash Flow from Investing Activities | -245.62 Cr | 48.65 Cr | -137.7 Cr | -249.2 Cr |
| Cash Flow from Financing Activitie | 235.92 Cr | -41.04 Cr | -41.71 Cr | 105.36 Cr |
| Net Cash Inflow / Outflow | 61.19 Cr | 132 Cr | -49.02 Cr | 50.87 Cr |
| Opening Cash & Cash Equivalents | -73.86 Cr | -12.68 Cr | 119.33 Cr | 70.31 Cr |
| Closing Cash & Cash Equivalent | -12.68 Cr | 119.33 Cr | 70.31 Cr | 121.18 Cr |
CONSOLIDATED BALANCE SHEET FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Equity - Authorised | 200 Cr | 200 Cr | 200 Cr | 200 Cr |
| Equity - Issued | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Equity Paid Up | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 521.15 Cr | 724.56 Cr | 709.38 Cr | 668.94 Cr |
| Securities Premium | 997.45 Cr | 1162.9 Cr | 1164.88 Cr | 1168.87 Cr |
| Capital Reserves | 67.7 Lk | 67.7 Lk | 67.7 Lk | 67.7 Lk |
| Profit & Loss Account Balance | -475.1 Cr | -436.55 Cr | -452.24 Cr | -496.25 Cr |
| Reserve excluding Revaluation Reserve | 521.15 Cr | 724.56 Cr | 709.38 Cr | 668.94 Cr |
| Shareholder's Funds | 697.18 Cr | 870.29 Cr | 860.52 Cr | 825.78 Cr |
| Minority Interest | 16.82 Cr | 13.43 Cr | 8.89 Cr | 39.34 Cr |
| Secured Loans | 323.17 Cr | 348.8 Cr | 340.49 Cr | 466.36 Cr |
| Term Loans - Banks | 214.37 Cr | 366.06 Cr | 372.82 Cr | 532.03 Cr |
| Term Loans - Institutions | 0 | 22.8 Lk | 0 | 0 |
| Unsecured Loans | 23 Cr | 14.07 Cr | 21.25 Cr | 18.95 Cr |
| Loans - Others | 5.32 Cr | 3.21 Cr | 82.8 Lk | 3.8 Cr |
| Deferred Tax Assets / Liabilities | -30.03 Cr | -4.68 Cr | 7.09 Cr | -98.3 Lk |
| Deferred Tax Assets | 125.27 Cr | 93.9 Cr | 62.31 Cr | 160.17 Cr |
| Deferred Tax Liability | 95.24 Cr | 89.22 Cr | 69.4 Cr | 159.18 Cr |
| Other Long Term Liabilities | 497.3 Cr | 491.4 Cr | 488.99 Cr | 591.64 Cr |
| Long Term Provisions | 8.62 Cr | 10.51 Cr | 13.19 Cr | 15.66 Cr |
| Total Non-Current Liabilities | 822.06 Cr | 860.11 Cr | 871.01 Cr | 1091.62 Cr |
| Trade Payables | 145.52 Cr | 193.94 Cr | 248.45 Cr | 281.06 Cr |
| Sundry Creditors | 145.52 Cr | 193.94 Cr | 248.45 Cr | 281.06 Cr |
| Other Current Liabilities | 241.94 Cr | 253.17 Cr | 298.85 Cr | 335.56 Cr |
| Advances received from customers | 20.36 Cr | 29.45 Cr | 24.15 Cr | 18.19 Cr |
| Current maturity - Others | 44.8 Lk | 0 | 0 | 0 |
| Short Term Borrowings | 67.02 Cr | 4.82 Cr | 3.44 Cr | 106.6 Cr |
| Secured ST Loans repayable on Demands | 67.02 Cr | 4.82 Cr | 3.44 Cr | 106.6 Cr |
| Working Capital Loans- Sec | 27.14 Cr | 4.82 Cr | 3.44 Cr | 106.6 Cr |
| Short Term Provisions | 10.77 Cr | 17.81 Cr | 19.58 Cr | 20.48 Cr |
| Provision for Tax | 35.2 Lk | 53.1 Lk | 2.47 Cr | 2.2 Cr |
| Total Current Liabilities | 465.25 Cr | 469.74 Cr | 570.32 Cr | 743.7 Cr |
| Total Liabilities | 2001.3 Cr | 2213.57 Cr | 2310.74 Cr | 2700.44 Cr |
| Gross Block | 1933.1 Cr | 2254.74 Cr | 2419.31 Cr | 2780.75 Cr |
| Less: Accumulated Depreciation | 550.72 Cr | 707.61 Cr | 866.31 Cr | 1022.59 Cr |
| Net Block | 1382.38 Cr | 1547.14 Cr | 1553 Cr | 1758.16 Cr |
| Capital Work in Progress | 30.01 Cr | 21.72 Cr | 18.18 Cr | 83.18 Cr |
| Non Current Investments | 26.28 Cr | 8.82 Cr | 9.69 Cr | 10.32 Cr |
| Long Term Investment | 26.28 Cr | 8.82 Cr | 9.69 Cr | 10.32 Cr |
| Quoted | 1.53 Cr | 1.64 Cr | 1.68 Cr | 1.89 Cr |
| Unquoted | 26.51 Cr | 8.94 Cr | 9.78 Cr | 8.43 Cr |
| Long Term Loans & Advances | 98.34 Cr | 98.52 Cr | 116.31 Cr | 149.7 Cr |
| Other Non Current Assets | 29.33 Cr | 35.04 Cr | 33.22 Cr | 19.22 Cr |
| Total Non-Current Assets | 1566.34 Cr | 1711.23 Cr | 1730.41 Cr | 2020.59 Cr |
| Unquoted | 26.51 Cr | 8.94 Cr | 9.78 Cr | 8.43 Cr |
| Inventories | 21.11 Cr | 29.97 Cr | 38.29 Cr | 42.67 Cr |
| Sundry Debtors | 186.6 Cr | 217.44 Cr | 302.51 Cr | 294.03 Cr |
| Debtors more than Six months | 0 | 72.64 Cr | 113.46 Cr | 138.35 Cr |
| Debtors Others | 234.48 Cr | 207.74 Cr | 236.58 Cr | 225.77 Cr |
| Cash and Bank | 40.85 Cr | 197.51 Cr | 196.64 Cr | 303.07 Cr |
| Cash in hand | 95.4 Lk | 1.5 Cr | 1.46 Cr | 1.08 Cr |
| Balances at Bank | 39.01 Cr | 195.1 Cr | 194.98 Cr | 301.82 Cr |
| Other Current Assets | 29.82 Cr | 12.55 Cr | 12.34 Cr | 12.82 Cr |
| Interest accrued on Investments | 2.9 Cr | 83.7 Lk | 1.12 Cr | 0 |
| Deposits with Government | 0 | 5.26 Cr | 5.38 Cr | 5.58 Cr |
| Prepaid Expenses | 5.68 Cr | 6 Cr | 5.47 Cr | 6.55 Cr |
| Short Term Loans and Advances | 156.58 Cr | 44.86 Cr | 30.56 Cr | 27.26 Cr |
| Advances recoverable in cash or in kind | 17.08 Cr | 36.45 Cr | 26.63 Cr | 23.47 Cr |
| Advance income tax and TDS | 3.08 Cr | 3.63 Cr | 3.78 Cr | 0 |
| Inter corporate deposits | 90 Lk | 0 | 0 | 0 |
| Total Current Assets | 434.96 Cr | 502.34 Cr | 580.34 Cr | 679.85 Cr |
| Net Current Assets (Including Current Investments) | -30.29 Cr | 32.59 Cr | 10.02 Cr | -63.85 Cr |
| Total Assets | 2001.3 Cr | 2213.57 Cr | 2310.74 Cr | 2700.44 Cr |
| Contingent Liabilities | 93.87 Cr | 54.06 Cr | 78.26 Cr | 73.35 Cr |
| Total Debt | 472.08 Cr | 407.63 Cr | 399.34 Cr | 672.76 Cr |
| Book Value | 51.57 | 62.12 | 60.99 | 58.02 |
| Adjusted Book Value | 51.57 | 62.12 | 60.99 | 58.02 |
STANDALONE BALANCE SHEET FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Equity - Authorised | 200 Cr | 200 Cr | 200 Cr | 200 Cr |
| Equity - Issued | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Equity Paid Up | 125.36 Cr | 139.01 Cr | 139.12 Cr | 139.29 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 747.82 Cr | 951.96 Cr | 993.98 Cr | 1031.74 Cr |
| Securities Premium | 997.45 Cr | 1162.9 Cr | 1164.88 Cr | 1168.87 Cr |
| Profit & Loss Account Balance | -246.66 Cr | -208.29 Cr | -168.1 Cr | -134.04 Cr |
| Reserve excluding Revaluation Reserve | 747.82 Cr | 951.96 Cr | 993.98 Cr | 1031.74 Cr |
| Shareholder's Funds | 923.78 Cr | 1097.69 Cr | 1145.12 Cr | 1188.58 Cr |
| Secured Loans | 124.77 Cr | 80.39 Cr | 105.02 Cr | 245.38 Cr |
| Term Loans - Banks | 52.06 Cr | 82.49 Cr | 111.97 Cr | 277.12 Cr |
| Term Loans - Institutions | 0 | 22.8 Lk | 0 | 0 |
| Unsecured Loans | 22.36 Cr | 1.64 Cr | 7.7 Cr | 15.15 Cr |
| Loans - Others | 4.68 Cr | 2.57 Cr | 18.7 Lk | 0 |
| Deferred Tax Assets / Liabilities | -27.33 Cr | -6.8 Lk | 10.28 Cr | 5.89 Cr |
| Deferred Tax Assets | 108.69 Cr | 79.35 Cr | 47.61 Cr | 109.57 Cr |
| Deferred Tax Liability | 81.36 Cr | 79.28 Cr | 57.89 Cr | 115.46 Cr |
| Other Long Term Liabilities | 247.39 Cr | 241.03 Cr | 231.29 Cr | 348.32 Cr |
| Long Term Provisions | 6.29 Cr | 7.79 Cr | 9.5 Cr | 11.13 Cr |
| Total Non-Current Liabilities | 373.47 Cr | 330.77 Cr | 363.79 Cr | 625.87 Cr |
| Trade Payables | 81.29 Cr | 96.34 Cr | 109 Cr | 132.37 Cr |
| Sundry Creditors | 81.29 Cr | 96.34 Cr | 109 Cr | 132.37 Cr |
| Other Current Liabilities | 92.97 Cr | 104 Cr | 95.56 Cr | 122.68 Cr |
| Advances received from customers | 14.96 Cr | 17.92 Cr | 17.08 Cr | 10.44 Cr |
| Current maturity - Others | 44.8 Lk | 0 | 0 | 0 |
| Short Term Borrowings | 67.02 Cr | 62.9 Lk | 0 | 101.42 Cr |
| Secured ST Loans repayable on Demands | 67.02 Cr | 62.9 Lk | 0 | 101.42 Cr |
| Working Capital Loans- Sec | 27.14 Cr | 62.9 Lk | 0 | 101.42 Cr |
| Short Term Provisions | 8.66 Cr | 14.12 Cr | 16.23 Cr | 16.96 Cr |
| Provision for Tax | 0 | 0 | 2.2 Cr | 2.2 Cr |
| Total Current Liabilities | 249.93 Cr | 215.08 Cr | 220.8 Cr | 373.44 Cr |
| Total Liabilities | 1547.18 Cr | 1643.55 Cr | 1729.71 Cr | 2187.89 Cr |
| Gross Block | 1058.23 Cr | 1176.63 Cr | 1274.55 Cr | 1510.41 Cr |
| Less: Accumulated Depreciation | 313.06 Cr | 402.78 Cr | 486.92 Cr | 572.34 Cr |
| Net Block | 745.17 Cr | 773.84 Cr | 787.63 Cr | 938.08 Cr |
| Capital Work in Progress | 27.61 Cr | 4.82 Cr | 9.22 Cr | 36.49 Cr |
| Non Current Investments | 365.66 Cr | 438.66 Cr | 474.93 Cr | 506.32 Cr |
| Long Term Investment | 365.66 Cr | 438.66 Cr | 474.93 Cr | 506.32 Cr |
| Quoted | 1.53 Cr | 1.64 Cr | 1.68 Cr | 1.89 Cr |
| Unquoted | 473.66 Cr | 573.55 Cr | 616.53 Cr | 665.94 Cr |
| Long Term Loans & Advances | 73.02 Cr | 62.33 Cr | 77.77 Cr | 129.21 Cr |
| Other Non Current Assets | 7.74 Cr | 7.75 Cr | 7.64 Cr | 64.72 Cr |
| Total Non-Current Assets | 1219.19 Cr | 1287.39 Cr | 1357.19 Cr | 1674.82 Cr |
| Unquoted | 473.66 Cr | 573.55 Cr | 616.53 Cr | 665.94 Cr |
| Inventories | 11.95 Cr | 17.3 Cr | 21.22 Cr | 21.02 Cr |
| Stores and Spare | 0 | 0 | 0 | 21.02 Cr |
| Sundry Debtors | 147.48 Cr | 160.24 Cr | 212.37 Cr | 204.17 Cr |
| Debtors more than Six months | 0 | 51.32 Cr | 87.04 Cr | 107.31 Cr |
| Debtors Others | 187.9 Cr | 159.13 Cr | 164.34 Cr | 154.25 Cr |
| Cash and Bank | 14.46 Cr | 119.96 Cr | 80.36 Cr | 237.33 Cr |
| Cash in hand | 50.5 Lk | 87.1 Lk | 72.3 Lk | 51 Lk |
| Balances at Bank | 13.54 Cr | 118.37 Cr | 79.46 Cr | 236.75 Cr |
| Other Current Assets | 32.02 Cr | 29.03 Cr | 35.79 Cr | 15.48 Cr |
| Interest accrued on Investments | 1.79 Cr | 69.8 Lk | 4.98 Cr | 4.4 Cr |
| Deposits with Government | 0 | 5.26 Cr | 5.26 Cr | 5.26 Cr |
| Interest accrued and or due on loans | 4.43 Cr | 4.43 Cr | 3 Lk | 3 Lk |
| Prepaid Expenses | 2.54 Cr | 3.24 Cr | 4.16 Cr | 5.29 Cr |
| Short Term Loans and Advances | 122.08 Cr | 29.63 Cr | 22.77 Cr | 35.07 Cr |
| Advances recoverable in cash or in kind | 13.16 Cr | 28.38 Cr | 23.17 Cr | 38.05 Cr |
| Advance income tax and TDS | 2.94 Cr | 3.35 Cr | 2.88 Cr | 0 |
| Inter corporate deposits | 90 Lk | 0 | 0 | 0 |
| Total Current Assets | 327.99 Cr | 356.16 Cr | 372.52 Cr | 513.07 Cr |
| Net Current Assets (Including Current Investments) | 78.06 Cr | 141.07 Cr | 151.72 Cr | 139.63 Cr |
| Total Assets | 1547.18 Cr | 1643.55 Cr | 1729.71 Cr | 2187.89 Cr |
| Contingent Liabilities | 294.77 Cr | 220.71 Cr | 188.08 Cr | 138.77 Cr |
| Total Debt | 239.97 Cr | 107.45 Cr | 121.5 Cr | 395.49 Cr |
| Book Value | 69.65 | 78.48 | 81.45 | 84.07 |
| Adjusted Book Value | 69.65 | 78.48 | 81.45 | 84.07 |
FINANCIAL RATIOS (CONSOLIDATED) FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -15.43 | 3.87 | 2.11 | 3.46 |
| CEPS(Rs) | -4.91 | 14.19 | 13.02 | 15.49 |
| Book NAV/Share(Rs) | 51.57 | 62.12 | 60.99 | 58.02 |
| Tax Rate(%) | 3.31 | 55.65 | 60.72 | 38.97 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 12.12 | 16.85 | 16.57 | 17.05 |
| EBIT Margin(%) | -10.81 | 13.3 | 8.77 | 9.25 |
| Pre Tax Margin(%) | -22.62 | 6.29 | 2.65 | 3.55 |
| PAT Margin (%) | -21.87 | 2.79 | 1.04 | 2.17 |
| Cash Profit Margin (%) | -6.1 | 14.14 | 10.71 | 11.31 |
| Performance Ratios | ||||
| ROA(%) | -10.44 | 1.85 | 0.78 | 1.65 |
| ROE(%) | -43.25 | 5.16 | 2.06 | 4.99 |
| ROCE(%) | -9.63 | 15.17 | 11.69 | 12.79 |
| Asset Turnover(x) | 0.48 | 0.66 | 0.75 | 0.76 |
| Sales/Fixed Asset(x) | 0.51 | 0.67 | 0.72 | 0.73 |
| Working Capital/Sales(x) | -33.32 | 42.8 | 168.89 | -29.88 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.96 | 1.5 | 1.38 | 1.36 |
| Receivable days | 67.32 | 52.87 | 56.1 | 57.06 |
| Inventory Days | 8.02 | 6.68 | 7.36 | 7.74 |
| Payable days | 75.04 | 174.56 | 190.39 | 203.27 |
| Valuation Parameters | ||||
| PER(x) | 0 | 69.83 | 124.52 | 97.82 |
| PCE(x) | -38.93 | 19.03 | 20.18 | 21.84 |
| Price/Book(x) | 3.7 | 4.34 | 4.31 | 5.83 |
| EV/Net Sales(x) | 2.8 | 2.84 | 2.28 | 2.66 |
| EV/Core EBITDA(x) | 19.69 | 15.81 | 12.37 | 14.66 |
| EV/EBIT(x) | -25.9 | 21.35 | 26 | 28.79 |
| EV/CE(x) | 1.41 | 1.79 | 1.67 | 3.39 |
| M Cap / Sales | 2.37 | 2.69 | 2.16 | 2.47 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -7.61 | 38.21 | 21.27 | 12.8 |
| Core EBITDA Growth(%) | -19.88 | 74.62 | 24.43 | 11.11 |
| EBIT Growth(%) | -455.43 | 269.45 | -20.03 | 18.93 |
| PAT Growth(%) | -95.12 | 117.61 | -54.71 | 134.45 |
| EPS Growth(%) | -28.28 | 125.05 | -45.42 | 63.87 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.73 | 0.47 | 0.47 | 0.83 |
| Current Ratio(x) | 0.93 | 1.07 | 1.02 | 0.91 |
| Quick Ratio(x) | 0.89 | 1.01 | 0.95 | 0.86 |
| Interest Cover(x) | -0.92 | 1.9 | 1.43 | 1.62 |
| Total Debt/Mcap(x) | 0.2 | 0.11 | 0.11 | 0.14 |
FINANCIAL RATIOS (STANDALONE) FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -15.28 | 2.75 | 2.89 | 2.44 |
| CEPS(Rs) | -8.37 | 9.11 | 9.28 | 9.2 |
| Book NAV/Share(Rs) | 69.65 | 78.48 | 81.45 | 84.07 |
| Tax Rate(%) | 6.59 | 52.8 | 30.25 | 38.1 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 12.07 | 17.28 | 16.81 | 17.85 |
| EBIT Margin(%) | -23.35 | 14.57 | 9.86 | 9.35 |
| Pre Tax Margin(%) | -33.68 | 9.54 | 5.73 | 4.99 |
| PAT Margin (%) | -31.46 | 4.5 | 4 | 3.09 |
| Cash Profit Margin (%) | -17.24 | 14.9 | 12.84 | 11.66 |
| Performance Ratios | ||||
| ROA(%) | -11.61 | 2.4 | 2.38 | 1.73 |
| ROE(%) | -25.87 | 3.9 | 3.61 | 2.95 |
| ROCE(%) | -12.55 | 10.46 | 8.02 | 7.21 |
| Asset Turnover(x) | 0.37 | 0.53 | 0.6 | 0.56 |
| Sales/Fixed Asset(x) | 0.55 | 0.76 | 0.82 | 0.79 |
| Working Capital/Sales(x) | 7.8 | 6.02 | 6.63 | 7.87 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.81 | 1.31 | 1.22 | 1.27 |
| Receivable days | 89.86 | 66.08 | 67.63 | 69.15 |
| Inventory Days | 7.33 | 6.28 | 6.99 | 7.01 |
| Payable days | 73.83 | 154.13 | 158.6 | 179.28 |
| Valuation Parameters | ||||
| PER(x) | 0 | 98.08 | 90.93 | 138.72 |
| PCE(x) | -22.82 | 29.63 | 28.29 | 36.76 |
| Price/Book(x) | 2.74 | 3.44 | 3.23 | 4.02 |
| EV/Net Sales(x) | 4.3 | 4.4 | 3.68 | 4.43 |
| EV/Core EBITDA(x) | 26.88 | 23.48 | 19.34 | 22.84 |
| EV/EBIT(x) | -18.43 | 30.2 | 37.29 | 47.35 |
| EV/CE(x) | 1.69 | 2.28 | 2.14 | 3.07 |
| M Cap / Sales | 3.93 | 4.41 | 3.63 | 4.29 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -11.55 | 39.58 | 18.33 | 9.32 |
| Core EBITDA Growth(%) | -23.74 | 63.4 | 19.96 | 11.54 |
| EBIT Growth(%) | -911 | 187.09 | -19.97 | 3.76 |
| PAT Growth(%) | -259.4 | 119.97 | 5.07 | -15.51 |
| EPS Growth(%) | -154.27 | 118.01 | 4.99 | -15.61 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.27 | 0.1 | 0.11 | 0.34 |
| Current Ratio(x) | 1.31 | 1.66 | 1.69 | 1.37 |
| Quick Ratio(x) | 1.26 | 1.58 | 1.59 | 1.32 |
| Interest Cover(x) | -2.26 | 2.89 | 2.39 | 2.14 |
| Total Debt/Mcap(x) | 0.1 | 0.03 | 0.03 | 0.08 |
SHARE HOLDING PATTERN FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 13.47 | 13.47 | 13.47 | 13.46 | 10.89 | 10.88 | 10.88 | 10.88 | 10.88 | 10.87 |
| FII % | 7.22 | 7.27 | 7.18 | 6.37 | 6.47 | 6.29 | 6.37 | 6.74 | 3.95 | 4.30 |
| DII % | 0.48 | 0.59 | 1.00 | 1.26 | 1.65 | 1.70 | 1.80 | 1.89 | 2.00 | 2.51 |
| Public % | 16.81 | 17.31 | 17.04 | 16.72 | 15.59 | 14.48 | 13.89 | 13.46 | 13.90 | 12.83 |
PEER COMPARISON FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
CORPORATE ACTIONS FOR HEALTHCARE GLOBAL
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 24-Oct-2024 | Board Meeting - Quarterly Results | 09-Nov-2024 |
| BSE 25-Jul-2024 | Board Meeting - Quarterly Results | 08-Aug-2024 |
| BSE 15-May-2024 | Board Meeting - Audited Results & Employees Stock Option Plan | 29-May-2024 |
| BSE 17-Jan-2024 | Board Meeting - Quarterly Results | 08-Feb-2024 |
| BSE 27-Oct-2023 | Board Meeting - Quarterly Results | 09-Nov-2023 |
| BSE 27-Jul-2023 | Board Meeting - Quarterly Results & Employees Stock Option Plan | 10-Aug-2023 |
| BSE 06-Jul-2023 | SAST - Intimation regarding execution of Share Purchase Agreement (SPA) for the acquisition of shares of Nagpur Cancer Hospital & Research Institute Private Limited. | |
| BSE 12-May-2023 | Board Meeting - Audited Results | 25-May-2023 |
| BSE 25-Jan-2023 | Board Meeting - Quarterly Results | 09-Feb-2023 |
| BSE 31-Oct-2022 | Board Meeting - Quarterly Results | 10-Nov-2022 |
| BSE 08-Sep-2022 | Book Closure - A.G.M. | 26-Sep-2022 29-Sep-2022 |
| BSE 08-Sep-2022 | AGM - A.G.M. | 29-Sep-2022 29-Sep-2022 |
| BSE 28-Jul-2022 | Board Meeting - Quarterly Results | 10-Aug-2022 |
| BSE 13-May-2022 | Board Meeting - Audited Results | 26-May-2022 |
| BSE 24-Jan-2022 | Board Meeting - Quarterly Results | 10-Feb-2022 |
| BSE 22-Nov-2021 | SAST - Intimation regarding investment in equity shares of Suchirayu Health Care Solutions Limited. | |
| BSE 29-Oct-2021 | Board Meeting - Quarterly Results | 11-Nov-2021 |
| BSE 01-Oct-2021 | SAST - Acquisition of minority stake from Shiv-Sun Medical Services LLP ('Shiv-Sun'), upon retirement from HCG Sun Hospitals LLP ('the LLP'), as a partner of the LLP. | |
| BSE 14-Sep-2021 | AGM - A.G.M. | 29-Sep-2021 29-Sep-2021 |
| BSE 14-Sep-2021 | Book Closure - A.G.M. | 26-Sep-2021 29-Sep-2021 |
| BSE 07-Sep-2021 | SAST - The Company has divested its entire equity holding of 34.5% (on a fully diluted basis) of the share capital in Strand Life Sciences Private Limited ('Strand') an associate of the Company to Reliance Strategic Business Ventures Limited ('RSBVL') pursuant to a Share Purchase Agreement executed by the Company on September 03, 2021 ('SPA') for a cash consideration of INR 157,77,57,968 (Indian Rupees O... | |
CORPORATE ANNOUNCEMENTS FOR HEALTHCARE GLOBAL
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of earnings call to discuss the unaudited financial results of the Company. |
| BSE 24-Oct-2024 | Intimation FILE | Board Meeting Intimation for Considering Approving And Taking On Record The Unaudited Financial Results For The Quarter And Six Months Ended Sept 30 2024 Along With Other Matters Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve and take on record the unaudited financial results for the quarter and six months ended Sept 30 2024. |
| BSE 16-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate stating the securities dematerialized/ rematerialized during the quarter ended Sept 30 2024 have been furnished to all the Stock Exchanges. |
| BSE 02-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Updates on Acquisition Intimation regarding completion of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited ("Vizag Hospital") by HealthCare Global Enterprises Limited from the Selling Shareholders. |
| BSE 01-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements Intimation regarding the execution of the (i) Amendment agreement to the Share Purchase Agreement entered into for the acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited (Vizag Hospital) by HealthCare Global Enterprises Limited from the selling shareholders and (ii) Amendment agreement to the shareholders agreement by and between HealthCare Global Enterprises Limited Vizag Hospital and its Continuing shareholders. |
| BSE 26-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report We are enclosing herewith -i) Consolidated report dated September 26 2024 of the scrutinizer signed by Mr. Pradeep B. Kulkarni Partner V. Sreedharan & Associates Company Secretaries on evoting and voting at the Annual General Meeting in compliance with the provisions of Sec 108 of the Companies Act 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014; andii) Voting results in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
| BSE 25-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of 26th AGM of the Company held on Wednesday September 25 2024 through video conferencing. |
| BSE 13-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation The officials of the Company will be meeting Investors /Analysts (Participants) at Mumbai on 19th and 20th September 2024. |
| BSE 09-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizers Report and Voting Results of the Postal Ballot for the agenda(s) listed in the Postal Ballot Notice dated August 08 2024 of the Company. |
| BSE 03-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the copies of newspaper advertisement published in Business Standard and Vijayavani (Kannada Language) regarding the dispatch of the Notice of 26th Annual General Meeting of the Company and the Annual Report of the Company for FY2023-24. |
| BSE 02-Sep-2024 | Intimation FILE | Annual General Meeting To Be Held On September 25 2024 Notice of the Annual General Meeting and Integrated Annual Report for the financial year 2023-24 |
| BSE 02-Sep-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. Notice of the 26th Annual General Meeting and Integrated Annual Report for the financial year 2023-24 |
| BSE 31-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement - 26th AGM Notice and the Annual Report of the Company for FY2023-24 |
| BSE 31-Aug-2024 | General Announcements FILE | Business Responsibility and Sustainability Reporting (BRSR) Business Responsibility and Sustainability Reporting (BRSR) for FY 2023-24 |
| BSE 29-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation The officials of the Company will be meeting Investors/Analysts (Participants) on September 04 2024 at 11.00 am. |
| BSE 22-Aug-2024 | General Announcements FILE | Clarification / Confirmation On News Item Appearing In Https://Health.Economictimes.Indiatimes.Com/ Clarification / Confirmation on news item appearing in https://health.economictimes.indiatimes.com/ |
| BSE 22-Aug-2024 | General - | Clarification sought from HealthCare Global Enterprises Ltd The Exchange has sought clarification from HealthCare Global Enterprises Ltd on August 22 2024 with reference to news appeared in https://health.economictimes.indiatimes.com/ dated August 22 2024 quoting "C-Care and Healthcare Global Enterprises ink pact to deliver cancer care services in Mauritius" The reply is awaited. |
| BSE 19-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript Please find attached herewith the Transcript of Earnings call held on August 09 2024 with Analyst/ Investors to discuss the Unaudited Financial results of the company for the quarter ended June 30 2024 |
| BSE 10-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement of Postal Ballot Notice dated August 08 2024 of the Company. |
| BSE 09-Aug-2024 | Intimation FILE | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Please find enclosed copy of the Postal Ballot Notice dated August 08 2024 ("Postal Ballot Notice") together with the Explanatory Statement that is being sent to the shareholders of HealthCare Global Enterprises Limited ("the Company"). |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Further to our intimation dated July 25 2024 this is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 09 2024 to discuss the Unaudited Financial Results of the Company for the quarter ended June 30 2024 is made available on the website of the Company www.hcgoncology.com. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement published in Business Standard (Engligh) and Vijaywani (Kannada) on August 09 2024 with regard to approval of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2024 at the meeting of Board of Directors held on August 08 2024. |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release We wish to inform you that the Board of Directors of the Company at their meeting held on August 08 2024 inter alia has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2024 ("Financial Results").We enclose herewith the communication being released to the Press on the Financial Results of the Company. |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation The Board of Directors of the Company at their meeting held on August 08 2024 inter alia has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2024 ("Financial Results"). We enclose herewith the Presentation on the Financial Results of the Company for the quarter ended June 30 2024. |
| BSE 08-Aug-2024 | General Announcements FILE | Reappointment Of Non-Executive Independent Director On The Board Of Healthcare Global Enterprises Limited ("The Company") Change in the tenure of office of Ms Geeta Mathur as an Independent Director of the Company from 03 years to 05 years with effect from June 17 2024. |
| BSE 08-Aug-2024 | General Announcements FILE | Reappointment Of Non-Executive Independent Director On The Board Of Healthcare Global Enterprises Limited ("The Company") Reappointment of Mr Rajagopalan Raghavan as Non-Executive Independent Director of the Company with effect from August 12 2024 for the second term of five (05) years. |
| BSE 08-Aug-2024 | Outcome FILE | Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2024 Unaudited Financial Results of the Company for the quarter ended June 30 2024; interalia Issue and allotment of equity shares re-appointment of Independent Director and Change in tenure of office of Independent Director of the Company. |
| BSE 08-Aug-2024 | Outcome FILE | Results - Financial Results For June 30 2024 Unuaudited Financial Results of the Company for the quarter ended June 30 2024 |
| BSE 25-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Earnings call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited |
| BSE 25-Jul-2024 | Intimation FILE | Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises Limited ("The Company") Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30 2024 ("Unaudited Financial Results"). |
INSIDER TRADING FOR HEALTHCARE GLOBAL
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 05-Sep-2024 05-Sep-2024 | Sell Market | 6,124 @ 0.00 (0.00 %) | JAGANNATH K |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 150 @ 0.00 (0.00 %) | Asha Nagaraj |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 375 @ 0.00 (0.00 %) | Ashwini P K |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 15,000 @ 0.00 (0.00 %) | Deepti Gautam Tewari |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 225 @ 0.00 (0.00 %) | Abdul Rahim |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 1,500 @ 0.00 (0.00 %) | Abhijeet Pratap Singh |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 450 @ 0.00 (0.00 %) | Narayanan V |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 300 @ 0.00 (0.00 %) | Navin Chugh |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 300 @ 0.00 (0.00 %) | Prafulkumar Navinchandra Dharani |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 1,087 @ 0.00 (0.00 %) | Prateek Jain |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 750 @ 0.00 (0.00 %) | Stuti Jain |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 1,500 @ 0.00 (0.00 %) | Sudeep Dey |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 450 @ 0.00 (0.00 %) | Aditya Kaura |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 9,000 @ 0.00 (0.01 %) | Venkataramanan P |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 300 @ 0.00 (0.00 %) | Santanu Das |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 750 @ 0.00 (0.00 %) | Sapna Agarwal |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 150 @ 0.00 (0.00 %) | Girish B R |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 375 @ 0.00 (0.00 %) | Vijay S Shanbhag |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 2,400 @ 0.00 (0.00 %) | Vineesh Kumar Ghei |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 225 @ 0.00 (0.00 %) | Yuva Kishore Terli |
| BSE 15-Sep-2023 15-Sep-2023 | Sell Market | 9,264 @ 0.00 (0.01 %) | P VENKATARAMANAN |
| BSE 08-Sep-2023 08-Sep-2023 | Sell Market | 2,000 @ 0.00 (0.00 %) | Ashutosh Kumar |
| BSE 18-Aug-2023 18-Aug-2023 | Buy ESOP | 38,500 @ 0.00 (0.00 %) | Meghraj Arvindrao Gore |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 400 @ 0.00 (0.00 %) | Rathna Raju |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 375 @ 0.00 (0.00 %) | Vijay S Shanbhag |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 4,500 @ 0.00 (0.00 %) | Vineesh Kumar Ghei |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 3,000 @ 0.00 (0.00 %) | Punitha Rani Singh |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 2,000 @ 0.00 (0.00 %) | Raghavendra Mruthyunjaya |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 3,500 @ 0.00 (0.00 %) | Sudeep Dey |
| BSE 10-Aug-2023 10-Aug-2023 | Buy ESOP | 1,000 @ 0.00 (0.00 %) | Surendra Kumar Patra |
BULK BLOCK DEALS FOR HEALTHCARE GLOBAL ENTERPRISES LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 30-Jun-2022 | Buy BULK | 1,750,500 @ 285.65 | ACESO COMPANY PTE LTD |
| BSE 30-Jun-2022 | Sell BULK | 1,750,500 @ 285.65 | BASAVALINGASHETTY SADASHIVIAH AJAIKUMAR |
| BSE 30-Jun-2022 | Buy BLOCK | 1,750,500 @ 285.65 | ACESO COMPANY PTE LTD |
| BSE 30-Jun-2022 | Sell BLOCK | 1,750,500 @ 285.65 | BASAVALINGASHETTY SADASHIVIAH AJAIKUMAR |
DIVIDEND BY HEALTHCARE GLOBAL ENTERPRISES LIMITED
No dividend details found
SPLIT / BONUS BY HEALTHCARE GLOBAL ENTERPRISES LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
